Centiva Capital, LP Dexcom Inc Put Options Transaction History

Centiva Capital, LP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$64.0 - $116.06 $134,400 - $243,726	-2,100 Reduced 21.0%	7,900 $529,000
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $1.1 Million - $1.4 Million	10,000 New	10,000 $1.13 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $2.81 Million - $3.27 Million	25,000 New	25,000 $3.21 Million
Q2 2022 Aug 15, 2022	SELL	$67.99 - $132.89 $13,597 - $26,577	-200 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $25,974 - $32,564	200 New	200 $107,000

1,019

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $32.6B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.